Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

This chapter looks at Americans’ exposure to artificial intelligence and views on its use in their lives. How much have Americans heard about AI and how often do they think they interact with it? How ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

Tracy J. Wholf is a senior coordinating producer of climate and environmental coverage for CBS News and Stations, based in New York. The Environmental Protection Agency announced Thursday it is ...

The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) found that certain lifestyle interventions improved cognition in older ...

The federal government is looking for researchers who can, in 5 years, develop stem cell treatments to repair brain damage caused by stroke, neurodegeneration, and trauma. The Functional Repair of ...

Northrop Grumman's pole position for the F/A-XX contract is threatened by shifting Pentagon funding priorities and possible program delays. The Pentagon's decision to underfund F/A-XX and consider an ...

Remember when all it took to win a national championship in college football was an elite roster, a hot-shot coach and a favorable schedule? The haves and have-nots were clearly defined, and success ...